Bridge to Life Announces First Commercial Use of VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System by Major U.S. Transplant Center Following FDA Clearance, Signaling Early Physician Confidence

Author: Bridge to Life, Ltd.

Posted Date: